Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting the JAK/STAT pathway in solid tumors
Zoya Qureshy, Daniel E. Johnson, Jennifer R. Grandis
Journal of Cancer Metastasis and Treatment (2020) Vol. 2020
Open Access | Times Cited: 114

Showing 26-50 of 114 citing articles:

Cancer Pathways Targeted by Berberine: Role of microRNAs
Mansoor Ali, Deepali Mishra, Rana P. Singh
Current Medicinal Chemistry (2024) Vol. 31, Iss. 32, pp. 5178-5198
Closed Access | Times Cited: 5
Ubiquitin-Specific Protease Inhibitors for Cancer Therapy: Recent Advances and Future Prospects
Mohamad Bakkar, Sara I. Khalil, Komal Bhayekar, et al.
Biomolecules (2025) Vol. 15, Iss. 2, pp. 240-240
Open Access
Folic acid grafted Tofacitinib loaded targeted Transfersomes for Transdermal delivery against Breast cancer.
Iqra Afzal, Ahmed Zeb, Danish Mazhar, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106711-106711
Closed Access
Side Effects of Immunosuppressant Drugs After Liver Transplant
Filippo Gabrielli, Elisa Bernasconi, Arianna Toscano, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 342-342
Open Access
Identification of new immune target and signaling for cancer immunotherapy
S. P. Narote, Sharav Desai, Vipul P. Patel, et al.
Cancer Genetics (2025)
Closed Access
Involvement and Therapeutic Implication of JAK-STAT Pathway in Cancer
Andleeb Rehman, Nihad Ashraf Khan, Gowhar Rashid, et al.
(2025), pp. 235-264
Closed Access
Single-cell transcriptional profiling reveals heterogeneity and developmental trajectories of Ewing sarcoma
Bo Hong, Yi Li, Ran Yang, et al.
Journal of Cancer Research and Clinical Oncology (2022) Vol. 148, Iss. 12, pp. 3267-3280
Closed Access | Times Cited: 20
Distinct immune-effector and metabolic profile of CD8+T cells in patients with autoimmune polyarthritis induced by therapy with immune checkpoint inhibitors
Karolina Benesova, Franziska V. Kraus, Rui A. Carvalho, et al.
Annals of the Rheumatic Diseases (2022) Vol. 81, Iss. 12, pp. 1730-1741
Open Access | Times Cited: 20
HER2-targeted therapy in colorectal cancer: a comprehensive review
Yeliz Benli, H. Arikan, Özge Akbulut
Clinical & Translational Oncology (2025)
Open Access
Transitional CXCL14+ cancer‐associated fibroblasts enhance tumour metastasis and confer resistance to EGFR‐TKIs, revealing therapeutic vulnerability to filgotinib in lung adenocarcinoma
Weijiao Xu, Haitang Yang, Ke Xu, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 4
Open Access
Synergism of TNF-α and IFN-γ triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes
Rajendra Karki, Bhesh Raj Sharma, Shraddha Tuladhar, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 32
Cancer Stem Cell (CSC) Inhibitors in Oncology—A Promise for a Better Therapeutic Outcome: State of the Art and Future Perspectives
Prashant S. Kharkar
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 24, pp. 15279-15307
Closed Access | Times Cited: 32
TYK2 in Cancer Metastases: Genomic and Proteomic Discovery
Dana C. Borcherding, Kevin He, Neha V. Amin, et al.
Cancers (2021) Vol. 13, Iss. 16, pp. 4171-4171
Open Access | Times Cited: 25
Expression Pattern of Leptin and Its Receptors in Endometrioid Endometrial Cancer
Dariusz Boroń, Robert Nowakowski, Beniamin Oskar Grabarek, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 13, pp. 2787-2787
Open Access | Times Cited: 24
Compostos bioativos identificados em Ayapana triplinervis: Uma revisão sobre mecanismos antitumorais
Camila Fernanda Rodrigues Romeiro, Lucas Villar Pedrosa da Silva Pantoja, Marcieni Ataíde de Andrade
Research Society and Development (2022) Vol. 11, Iss. 6, pp. e0811628478-e0811628478
Open Access | Times Cited: 17
MEK Inhibition Synergizes with TYK2 Inhibitors in NF1-Associated Malignant Peripheral Nerve Sheath Tumors
Dana C. Borcherding, Neha V. Amin, Kevin He, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 8, pp. 1592-1604
Open Access | Times Cited: 10
Potential drug repurposing of ruxolitinib to inhibit the JAK/STAT pathway for the treatment of patients with epithelial ovarian cancer
Irfan Yunianto, Margaret J. Currie, Kenny Chitcholtan, et al.
Journal of Obstetrics and Gynaecology Research (2023) Vol. 49, Iss. 11, pp. 2563-2574
Open Access | Times Cited: 9
Synthesis and clinical application of small-molecule inhibitors of Janus kinase
Jingyi Zhang, Jinfeng Sun, Peng Nie, et al.
European Journal of Medicinal Chemistry (2023) Vol. 261, pp. 115848-115848
Closed Access | Times Cited: 9
Predicting synergistic anticancer drug combination based on low-rank global attention mechanism and bilinear predictor
Yanglan Gan, Xingyu Huang, Wenjing Guo, et al.
Bioinformatics (2023) Vol. 39, Iss. 10
Open Access | Times Cited: 9
Janus kinase inhibitor overcomes resistance to immune checkpoint inhibitor treatment in peritoneal dissemination of gastric cancer in C57BL/6 J mice
Wan-Ying Du, Hiroki Masuda, Koji Nagaoka, et al.
Gastric Cancer (2024) Vol. 27, Iss. 5, pp. 971-985
Open Access | Times Cited: 3
Inhibition of STAT3: A promising approach to enhancing the efficacy of chemotherapy in medulloblastoma
Sachindra Kumar, Dube Aakash Arwind, Harish Kumar B, et al.
Translational Oncology (2024) Vol. 46, pp. 102023-102023
Open Access | Times Cited: 3
Anticancer Potential of Flavonoids: Their Role in Cancer Prevention and Health Benefits
Yeonhee Pyo, Ki Han Kwon, Yeon Ja Jung
Foods (2024) Vol. 13, Iss. 14, pp. 2253-2253
Open Access | Times Cited: 3
Bridging Radiotherapy to Immunotherapy: The IFN–JAK–STAT Axis
Lewis Zhichang Shi, James A. Bonner
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 22, pp. 12295-12295
Open Access | Times Cited: 21
The Cancer Stem Cell Niche in Ovarian Cancer and Its Impact on Immune Surveillance
Srishti Jain, Stephanie Annett, Maria P. Morgan, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 8, pp. 4091-4091
Open Access | Times Cited: 20
Tumor-associated macrophages promote migration and invasion via modulating IL-6/STAT3 signaling in renal cell carcinoma
Shaojun Chen, Subo Qian, Lin Zhang, et al.
International Immunopharmacology (2022) Vol. 111, pp. 109139-109139
Open Access | Times Cited: 15

Scroll to top